| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
8-K: Regulation FD Disclosure
As previously disclosed, pursuant to an agreement entered into between the Research Development Foundation (“RDF”) and a wholly-owned subsidiary of Pacira BioSciences, Inc. (the “Company” or “Pacira”), the Company was required to pay RDF... |
| 12 Nov 2026 | SC TO-T/A |
| 12 Nov 2026 | SC 14D9/A |
| 05 Nov 2026 | 10-Q - PCRX - 9.30.2026 |
| 05 Nov 2026 |
8-K: Regulation FD Disclosure
As previously disclosed, on October 8, 2026, Pacira BioSciences, Inc., a Delaware corporation (the “Company” or “Pacira”), entered into the Agreement and Plan of Merger (the “Merger Agreement”) with Viatris Inc., a Delaware corporation (... |
| 03 Nov 2026 |
Form 4: Cross Shawn, Chief Financial Officer
Gave up 9,540 shares to cover exercise price or tax ($347K) |
| 03 Nov 2026 | SC 14D9/A |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 30 Oct 2026 | SC 14D9 |
| 30 Oct 2026 | SC TO-T |
| 13 Oct 2026 | SCHEDULE 13D/A |
| 09 Oct 2026 |
Form 4: Riker Lauren, Senior Vice President, Finance
Received 6,000 shares by exercise or conversion ($194K) · Sold 6,000 shares ($218K) |
| 08 Oct 2026 | SC TO-C |
| 08 Oct 2026 | SC14D9C |
| 08 Oct 2026 | 144 |
| 08 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of October 8, 2026 (the “Agreement Date”), by and among Viatris Inc., a Delaware corporation (“Parent”), Peach Purchaser Sub Inc., a Delaware corporation an... |
| 08 Oct 2026 | SC TO-C |
| 18 Aug 2026 |
Form 4: Slonin Jonathan, Chief Medical Officer
Sold 3,040 shares ($70.6K) |
| 17 Aug 2026 | 144 |
| 07 Aug 2026 | SCHEDULE 13G |
Loading...